Aggressive lipid-lowering therapy after percutaneous coronary intervention-for whom and how?
Percutaneous coronary intervention (PCI) has been established as a definitive method to treat obstructive coronary artery disease. The procedure on its own, however, is insufficient to ensure optimal longterm patient outcomes as it is also necessary to achieve good control of relevant risk factors....
Saved in:
| Main Authors: | , |
|---|---|
| 格式: | Article |
| 出版: |
Europa Group
2022
|
| 主題: | |
| 在線閱讀: | http://eprints.um.edu.my/43936/ |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
成為第一個發表評論!